Daniel Byrd

558 total citations
20 papers, 440 citations indexed

About

Daniel Byrd is a scholar working on Virology, Immunology and Oncology. According to data from OpenAlex, Daniel Byrd has authored 20 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 14 papers in Immunology and 3 papers in Oncology. Recurrent topics in Daniel Byrd's work include HIV Research and Treatment (12 papers), Complement system in diseases (6 papers) and Immunotherapy and Immune Responses (5 papers). Daniel Byrd is often cited by papers focused on HIV Research and Treatment (12 papers), Complement system in diseases (6 papers) and Immunotherapy and Immune Responses (5 papers). Daniel Byrd collaborates with scholars based in United States, China and France. Daniel Byrd's co-authors include Qigui Yu, Tohti Amet, Padma Sampath, Ningjie Hu, Yi Zhang, Stephen H. Thorne, Feng Li, Yuqiao Sheng, Jie Lan and Xuebin Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Daniel Byrd

19 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Byrd United States 13 207 127 114 104 90 20 440
Nicolas Ruffin Sweden 16 396 1.9× 281 2.2× 218 1.9× 54 0.5× 30 0.3× 33 803
Mercedes Bermejo Spain 14 281 1.4× 273 2.1× 142 1.2× 92 0.9× 20 0.2× 23 554
JoAnn C. Castelli United States 7 320 1.5× 54 0.4× 266 2.3× 101 1.0× 43 0.5× 9 539
Kamalpreet Arora United States 7 153 0.7× 103 0.8× 272 2.4× 57 0.5× 47 0.5× 8 402
John Bui United States 10 173 0.8× 251 2.0× 184 1.6× 57 0.5× 97 1.1× 12 567
Roanna Ueda United States 7 382 1.8× 27 0.2× 188 1.6× 88 0.8× 74 0.8× 9 615
Joseph W. Maciaszek United States 7 521 2.5× 92 0.7× 125 1.1× 108 1.0× 33 0.4× 10 682
Matthias Hamdorf Germany 8 207 1.0× 195 1.5× 253 2.2× 37 0.4× 66 0.7× 12 537
Kenneth Ganley United States 6 397 1.9× 121 1.0× 89 0.8× 209 2.0× 94 1.0× 7 608
Marc Potempa United States 10 200 1.0× 151 1.2× 129 1.1× 51 0.5× 38 0.4× 15 456

Countries citing papers authored by Daniel Byrd

Since Specialization
Citations

This map shows the geographic impact of Daniel Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Byrd more than expected).

Fields of papers citing papers by Daniel Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Byrd. The network helps show where Daniel Byrd may publish in the future.

Co-authorship network of co-authors of Daniel Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Byrd. A scholar is included among the top collaborators of Daniel Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Byrd. Daniel Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keswani, Rajesh N., Daniel Byrd, J. Alex Heller, et al.. (2021). Amalgamation of cloud-based colonoscopy videos with patient-level metadata to facilitate large-scale machine learning. SHILAP Revista de lepidopterología. 9(2). E233–E238. 3 indexed citations
2.
Li, Feng, Yuqiao Sheng, Padma Sampath, et al.. (2020). CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency. Journal for ImmunoTherapy of Cancer. 8(1). e000131–e000131. 90 indexed citations
3.
Amet, Tohti, Jie Lan, Kai Yang, et al.. (2016). Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack. AIDS Research and Human Retroviruses. 32(10-11). 1100–1112. 9 indexed citations
4.
Meng, Zhefeng, Daniel Byrd, Tohti Amet, et al.. (2016). Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33+CD11b+HLA-DR+ Cells. Medicine. 95(15). e3285–e3285. 7 indexed citations
5.
Meng, Zhefeng, Daniel Byrd, Tohti Amet, et al.. (2016). Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33⁺CD11b⁺HLA-DR⁺ Cells: A Cross-Sectional Study. 1 indexed citations
6.
Rojas, Juan J., Padma Sampath, Braulio Bonilla, et al.. (2016). Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies. Cell Reports. 15(2). 264–273. 29 indexed citations
7.
8.
Wang, Ting, Linden A. Green, Samir K. Gupta, et al.. (2014). Intracellular Nef Detected in Peripheral Blood Mononuclear Cells from HIV Patients. AIDS Research and Human Retroviruses. 31(2). 217–220. 26 indexed citations
9.
Byrd, Daniel, et al.. (2014). Primary Human Macrophages Serve as Vehicles for Vaccinia Virus Replication and Dissemination. PMC.
10.
Amet, Tohti, Daniel Byrd, Ningjie Hu, et al.. (2014). BST-2 Expression in Human Hepatocytes is Inducible by All Three Types of Interferons and Restricts Production of Hepatitis C Virus. Current Molecular Medicine. 14(3). 349–360. 27 indexed citations
11.
Hu, Sishun, Marwan Ghabril, Tohti Amet, et al.. (2014). HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects. PLoS ONE. 9(2). e86964–e86964. 7 indexed citations
12.
Byrd, Daniel, et al.. (2014). Primary Human Macrophages Serve as Vehicles for Vaccinia Virus Replication and Dissemination. Journal of Virology. 88(12). 6819–6831. 29 indexed citations
13.
Lan, Jie, Kai Yang, Daniel Byrd, et al.. (2014). Provirus Activation Plus CD59 Blockage Triggers Antibody-Dependent Complement-Mediated Lysis of Latently HIV-1–Infected Cells. The Journal of Immunology. 193(7). 3577–3589. 18 indexed citations
14.
Yu, Qigui, Shannon E. McCaw, Daniel Byrd, et al.. (2013). Association of Neisseria gonorrhoeae OpaCEA with Dendritic Cells Suppresses Their Ability to Elicit an HIV-1-Specific T Cell Memory Response. PLoS ONE. 8(2). e56705–e56705. 18 indexed citations
15.
Byrd, Daniel, Tohti Amet, Ningjie Hu, et al.. (2013). Primary Human Leukocyte Subsets Differentially Express Vaccinia Virus Receptors Enriched in Lipid Rafts. Journal of Virology. 87(16). 9301–9312. 18 indexed citations
16.
Amet, Tohti, Marwan Ghabril, Naga Chalasani, et al.. (2011). CD59 Incorporation Protects Hepatitis C Virus Against Complement-Mediated Destruction. Hepatology. 55(2). 354–363. 44 indexed citations
17.
Amet, Tohti, Daniel Byrd, Kavita Shah, et al.. (2011). Direct Effects of HIV-1 Tat on Excitability and Survival of Primary Dorsal Root Ganglion Neurons: Possible Contribution to HIV-1-Associated Pain. PLoS ONE. 6(9). e24412–e24412. 27 indexed citations
18.
Hu, Weiguo, Qigui Yu, Daniel Byrd, et al.. (2010). A high affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: Implications for treatment of HIV-1/AIDS. Molecular Immunology. 47(13). 2250–2250. 1 indexed citations
19.
Hu, Weiguo, Qigui Yu, Daniel Byrd, et al.. (2009). A High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDS. The Journal of Immunology. 184(1). 359–368. 36 indexed citations
20.
Brown, George P., Kwang Moon Yang, Ouathek Ouerfelli, et al.. (1997). 3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line.. PubMed. 282(3). 1291–7. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Ruffin Breakdown of academic impact, for papers by Mercedes Bermejo Breakdown of academic impact, for papers by JoAnn C. Castelli Breakdown of academic impact, for papers by Kamalpreet Arora Breakdown of academic impact, for papers by John Bui Breakdown of academic impact, for papers by Roanna Ueda Breakdown of academic impact, for papers by Joseph W. Maciaszek Breakdown of academic impact, for papers by Matthias Hamdorf Breakdown of academic impact, for papers by Kenneth Ganley Breakdown of academic impact, for papers by Marc Potempa
Rankless by CCL
2026